CITRINE GLOBAL, CORP. - Annual Report: 2015 (Form 10-K)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________
FORM 10-K
_________________________________
ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2015
Commission file number 333-168527
(Exact Name Of Registrant As Specified In Its Charter)
Delaware | 68-0080601 |
(State of Incorporation) | (I.R.S. Employer Identification No.) |
40 Wall Street, 28th Floor, New York, NY | 10005 |
(Address of Principal Executive Offices) | (ZIP Code) |
Securities Registered Pursuant to Section 12(g) of The Act: Common Stock, $0.0001
Indicate by check
mark whether the registrant (1) has filed all reports required to be filed by Section 13
or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of
Regulation S-K is not contained herein, and will not be contained, to the best of the
registrant's knowledge, in the definitive proxy or information statements incorporated by
reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨
On June
30, 2015,
the aggregate market value of the 82,142,210 common stock held by non-affiliates of the
registrant was approximately $2,464,266 based on the closing price of $0.03 per
share of the Registrants common
stock on June 30, 2015.
On April 4, 2016, the Registrant had 144,419,173 shares of common
stock outstanding.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act) or a smaller reporting company .
Large accelerated filer ¨ | Accelerated filer ¨ | Non-Accelerated filer ¨ | Smaller reporting company x |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
Cautionary Statement regarding Forward-Looking Statements
This Annual Report contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended (the "Act") and Section 21E of the
Securities Exchange Act of 1934 (the "Exchange Act"). These forward-looking
statements relate to future events or our future financial performance. In
some cases, you can identify forward-looking statements by terminology such
as "may," "should," "expects," "plans," "anticipates," "believes,"
"estimates," "predicts," "potential," or "continue" or the negative of these
terms or other comparable terminology. These forward-looking statements are
only predictions and involve known and unknown risks, uncertainties and
other factors, including the risks set out in the section hereof entitled
"Risk Factors" and the risks set out below, any of which may cause our or
our industry's actual results, levels of activity, performance or
achievements to be materially different from any future results, levels of
activity, performance or achievements expressed or implied by these
forward-looking statements.
These risks include, by way of example
and not in limitation:
- risks related to our ability to continue as a
going concern;
- the uncertainty of profitability based upon our history
of losses;
- risks related to failure to obtain adequate financing on a
timely basis and on acceptable terms for our projects;
- risks related
to our ability to fund our sales and marketing costs;
- risks related to
conducting business internationally due to our operations in Israel;
-
risks related to our ability to commercially exploit our IDSS technology
into commercial products;
- risks related to our ability to successfully
prosecute and protect our intellectual property;
- risks related to tax
assessments; and
- other risks and uncertainties related to our
prospects, properties, and business strategy.
The above list is not
an exhaustive list of the factors that may affect any of our forward-looking
statements. These and other risks described in this report should be
considered carefully and readers should not place undue reliance on our
forward-looking statements.
Forward-looking statements are made based
on management's beliefs, estimates and opinions on the date the
forward-looking statements are made, and we undertake no obligation to
update forward-looking statements should these beliefs, estimates, and
opinions or other circumstances change. Although we believe that the
expectations reflected in the forward-looking statements are reasonable, we
cannot guarantee future results, levels of activity, performance, or
achievements. Except as required by applicable law, including the securities
laws of the United States, we do not intend to update any of the
forward-looking statements to conform these forward-looking statements to
actual results.
Our financial statements are stated in United States
dollars ("US$") and are prepared in accordance with United States generally
accepted accounting principles ("GAAP"). In this Annual Report, unless
otherwise specified, all dollar amounts are expressed in United States
dollars and all references to "common stock" refer to the shares of our
common stock. As used in this Annual Report, the terms "we," "us," "our," "BreedIT,"
the "Company" and the "Registrant" mean BreedIT Corp. unless the context
clearly requires otherwise.
PART I
ITEM 1. DESCRIPTION OF BUSINESS Back to Table of Contents
Formation and Background
We were incorporated on May 26, 2010, in the State of Delaware. Our authorized capital consists of 500,000,000 shares of our common stock (the "Common Shares"), par value of $0.0001. Our principal executive offices are currently located at the following address: 40 Wall Street, 28th Floor, New York, NY 10005-1313.
We were organized for the purpose of developing and marketing software for an online gaming platform and entering into licensing agreements with online game service providers world-wide. Our gaming platform enabled our customers to offer games of skill using our platform as part of their member services. During our year ended December 31, 2011, we generated revenues of approximately $93,000, virtually all of which was from the sale of a single license to one customer. During our year ended December 31, 2012, our revenues declined to approximately $6,000. This decline and our inability to successfully market our online gaming platform led our management and principal shareholders to reevaluate our business plan during 2013. As part of management's reevaluation, the Company conducted discussions with certain of its principal shareholders and other persons in Israel, during which the Company was introduced to Dr. Oded Sagee, the founder of BreedIT Ltd, organized under the laws of the State of Israel ("BreedIT Israel").
Recent Corporate Developments
In our report on Form 8-K filed August 19, 2013, we disclosed that we had entered into a preliminary agreement (the "Preliminary Agreement") with BreedIT Israel and its founder, Dr. Oded Sagee, pursuant to which we agreed to acquire 66.67% of BreedIT Israel's capital stock. Subsequently, we were issued 200 shares of BreedIT Israel's capital stock ("Ordinary Shares") which represent 66.67% of BreedIT's outstanding Ordinary Shares with the founder, Dr. Oded Sagee owning the remaining 100 Ordinary Shares, representing 33.33% of the outstanding Ordinary Shares.
On November 8, 2013, our board of directors authorized the filing with the State of Delaware of a Certificate of Amendment to its Certificate of Incorporation changing our name from Progaming Platforms Corp. to BreedIT Corp. On January 14, 2014, Mr. Yoel Yogev, the Registrant's newly-appointed Chief Executive Officer, accepted his appointment to become a member of the Registrant's Board of directors. On February 27, 2014, the Company announced that it had successfully completed the raise of the US$1,000,000 required under its agreements with BreedIT Israel.
On August 28, 2015, the Company entered into a separation agreement with BreedIT Ltd., the Company's majority-owned subsidiary ("BreedIT Israel"), BreedIT Israel's founder and minority stockholder, Dr. Oded Sagee ("Dr. Sagee") and Star Biotech Ltd, an Israeli company controlled by Dr. Sagee ("SB"). the Company and Dr. Sagee agreed to enter into the Separation Agreement based upon the determination by the Company that it had fulfilled its obligation to fund up to but not more than $1 million on behalf of BreedIT Israel but was not willing to continue to fund BreedIT Israel as a result of the financial condition and result of operations of BreedIT Israel and the estimate of future revenues presented by Dr. Sagee. The company agreed that its Equity Interest shall be diluted from sixty-six and two-thirds (66 2/3%) percent to nineteen (19%) percent. SB shall have the option to acquire the company's shares for the sum of $50,000 and in the event that the option is not exercised, SB shall pay the Company an amount equal to ten (10%) percent of BreedIT Israel's gross profits, for a period of three (3) years.
On November 22, 2015 BreedIt entered into preliminary merger agreement with Novomic Ltd. an Israeli company. On February 8, 2016, BreedIt entered in a definitive material agreement for the merger which is expected to close during Q2 2016.
ITEM 1A. RISK FACTORS Back to Table of Contents
Risks Relating to Our Business
Our executive officers and directors have significant voting power and may take actions that may be different than actions sought by our other stockholders.
Our officers and directors own approximately 18% of the outstanding shares of our common stock. These stockholders will be able to exercise significant influence over all matters requiring stockholder approval. This influence over our affairs might be adverse to the interest of our other stockholders. In addition, this concentration of ownership could delay or prevent a change in control and might have an adverse effect on the market price of our common stock.
Our officers and directors are located in Israel and our assets may also be held from time to time outside of the United States.
Since all of our officers and directors are currently located in and/or are residents of Israel, any attempt to enforce liabilities upon such individuals under the U.S. federal securities and bankruptcy laws may be difficult. In accordance with the Israeli Law on Enforcement of Foreign Judgments, 5718-1958, and subject to certain time limitations (the application to enforce the judgment must be made within five years of the date of judgment or such other period as might be agreed between Israel and the United States), an Israeli court may declare a foreign civil judgment enforceable if it finds that:
- the
judgment was rendered by a court which was, according to the laws of the
State in which the court is located, competent to render the judgment;
-
the judgment may no longer be appealed;
- the obligation imposed by the
judgment is enforceable according to the rules relating to the
enforceability of judgments in Israel and the substance of the judgment is
not contrary to public policy; and
- the judgment is executory in the
State in which it was given.
An Israeli court will not declare a foreign
judgment enforceable if:
- the judgment was obtained by fraud;
-
there is a finding of lack of due process;
- the judgment was rendered
by a court not competent to render it according to the laws of private
international law in Israel;
- the judgment is in conflict with another
judgment that was given in the same matter between the same parties and that
is still valid; or
- the time the action was instituted in the foreign
court, a suit in the same matter and between the same parties was pending
before a court or tribunal in Israel.
Furthermore, Israeli courts may not adjudicate a claim based on a violation of U.S. securities laws if the court determines that Israel is not the most appropriate forum in which to bring such a claim. Even if an Israeli court agrees to hear such a claim, it may determine that Israeli law, not U.S. law, is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proven as a fact, which can be a time-consuming and costly process.
Our assets may also be held from time to time outside of the United States. Since our directors and executive officers are foreign citizens and do not reside in the United States, it may be difficult for courts in the United States to obtain jurisdiction over our foreign assets or persons, and as a result, it may be difficult or impossible for you to enforce judgments rendered against us or our directors or executive officers in United States courts. Thus, investing in us may pose a greater risk because should any situation arise in the future in which you would have a cause of action against these persons or against us, you may face potential difficulties in bringing lawsuits or, if successful, in collecting judgments against these persons or against the Company.
Regulatory Risks
We face risks related to compliance with corporate governance laws and financial reporting standards.
The Sarbanes-Oxley Act of 2002, as well as related new rules and regulations implemented by the Securities and Exchange Commission and the Public Company Accounting Oversight Board, require changes in the corporate governance practices and financial reporting standards for public companies. These new laws, rules and regulations, including compliance with Section 404 of the Sarbanes-Oxley Act of 2002 relating to internal control over financial reporting, have materially increased the legal and financial compliance costs of small companies and have made some activities more time-consuming and more burdensome.
We may not have effective internal controls.
In connection with Section 404 of the Sarbanes-Oxley Act of 2002, we need to assess the adequacy of our internal control, remedy any weaknesses that may be identified, validate that controls are functioning as documented and implement a continuous reporting and improvement process for internal controls. We may discover deficiencies that require us to improve our procedures, processes and systems in order to ensure that our internal controls are adequate and effective and that we are in compliance with the requirements of Section 404 of the Sarbanes-Oxley Act. If the deficiencies are not adequately addressed, or if we are unable to complete all of our testing and any remediation in time for compliance with the requirements of Section 404 of the Sarbanes-Oxley Act and the SEC rules under it, we would be unable to conclude that our internal controls over financial reporting are designed and operating effectively, which could adversely affect investor confidence in our internal controls over financial reporting.
Risks Relating to Operating in Israel.
We conduct our operations in Israel and therefore our results may be adversely affected by political, economic and military instability in Israel or the Middle East.
Our subsidiary offices and our officers and directors are located in Israel. Accordingly, political, economic and military conditions in Israel and the Middle East may directly affect our business. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its Arab neighbors. Any hostilities involving Israel or the interruption or curtailment of trade within Israel or between Israel and its trading partners could adversely affect our operations and could make it more difficult for us to raise capital. Since September 2000, terrorist violence in Israel has increased significantly and negotiations between Israel and Palestinian representatives have not achieved a peaceful resolution of the conflict. The establishment in 2006 of a government in Gaza by representatives of the Hamas militant group has created additional unrest and uncertainty in the region.
Further,
Israel is currently engaged in an armed conflict with Hamas, which until
Operation Cast Lead in January 2009 had involved thousands of missile
strikes and had disrupted most day-to-day civilian activity in southern
Israel. The missile attacks by Hamas did not target Tel Aviv, the location
of our principal executive offices; however, any armed conflict, terrorist
activity or political instability in the region may negatively affect
business conditions and could significantly harm our results of operations.
ITEM 1B. UNRESOLVED STAFF
COMMENTS Back to Table of Contents None. ITEM 2. PROPERTIES
Back to Table of Contents Our corporate office is at 40
Wall Street, 28th Floor New York, NY 10005. The space is sufficient until we actively commence our
new business. At such time, we believe that adequate
facilities will be available at terms satisfactory to the Company. ITEM 3. LEGAL PROCEEDINGS Back to Table of Contents
We know of no
material, active or pending legal proceedings against our Company, nor of
any proceedings that a governmental authority is contemplating against us.
We know of no material proceedings to which any of our directors, officers,
affiliates, owner of record or beneficially of more than 5 percent of our
voting securities or security holders is an adverse party or has a material
interest adverse to our interest.
ITEM 4. MINE SAFETY DISCLOSURES
Back to Table of Contents
Not Applicable.
PART II
ITEM 5.
MARKET FOR REGISTRANT'S COMMON STOCK AND RELATED STOCKHOLDER MATTER Back to Table of Contents Market Information Our Common Shares are traded on
the over-the-counter market and quoted on the OTCQB under the symbol BRDT. The high and the low bid prices for our shares of common
stock are based on inter-dealer prices, without retail mark-up, markdown, or
commission, and may not represent actual transactions. The table below sets
forth the range of high and low bid information for our shares of common shares
as quoted on the OTCQB for each of the quarters during the fiscal year ended
December 31, 2015, 2014 and 2013. This information has been adjusted to reflect
the 10-for-1 forward stock split that was effective March 2, 2012. Fiscal 2015 Fiscal 2014 Fiscal 2013 High Low High Low High Low First Quarter ended
March 31 $
0.09 $
0.06 $ 0.88 $ 0.11 $
0.10 $ 0.03 Second Quarter ended
June 30 $
0.07 $
0.03 $
0.68 $ 0.31 $
0.06 $
0.01 Third Quarter ended
September 30 $
0.04 $
0.02 $
0.41 $ 0.18 $
0.06 $
0.01 Fourth Quarter ended
December 31 $
0.03 $
0.01 $
0.18 $ 0.07 $
0.19 $
0.04 Holders of our Common Shares On March 3, 2014 the Company issued 1,000,000 restricted
shares of common stock in consideration for investor relations (IR) services
provided to the Company. The shares were valued at $480,000 based on the
closing price of the Company's common stock on the date of grant. From January 23, 2014 to September 30, 2014 the Company sold
to 10 non-US private accredited investors a total of 6,461,666 shares for
cash consideration of $923,000 at an average price of $0.143. From March 10, 2014 through September 30, 2014, the Company
sold to 12 non-US private accredited investors, a total of 3,270,000 units
for cash consideration of $667,750 at an average price of $0.204 (the
"Units"), each unit comprised of one share of common stock, one class C
warrant with 24 months term exercisable at a price of $0.35; The relative
fair value of the stock with attached warrants was $189,300 for the common
stock, $478,450 for class C warrants. On February 24, 2014 and March 13, 2014 3 share and warrant
holders exercised warrants and were issued 1,144,262 shares for cash
consideration of $48,000. During the period from February 19, 2014 to March 4, 2014,
the Company granted a total of 5,050,000 stock options (the "Options") to 4
Company directors and officers who are also minatory owners. The Options,
which are fully vested, are exercisable at a price of $0.05 per Share.
1,400,000 options were valued using the Black-Scholes model with 128%
volatility and 2.17% discount rate and 3,650,000 were valued using the
Black-Scholes model with 154% volatility and 2.17% discount rate for a total
of $2,594,210. On March 12, 2014 the Company issued 30,000 warrants with
term of 36 months, exercisable at $0.60 per share to 1 entity in
consideration for public relations services provided to the company. The
warrants were valued using the Black-Scholes model with 117% volatility and
0.22% discount rate for a total of $16,134. On April 1, 2014 and April 7, 2014 the Company sold to 2
private accredited investors, a total of 1,215,000 units for cash
consideration of $250,150 at an average price of $0.206 (the "Units"), each
unit comprised of one share of common stock, one class C warrant with 24
months term exercisable at a price of $0.35; The relative fair value of the
stock with attached warrants was $61,984 for the common stock, $188,166 for
class C warrants. On October 2, 2014 850,000 stock options (the "Options") to
1 Company officer who is also a minority owner. The Options, vest over 9
quarters and are exercisable at a price of $0.05 per Share. The options were
valued using the Black-Scholes model with 281% volatility and 0.23% discount
rate for a total value of $152,955 with $52,185 expensed during Q4 2014 and
$12,596 to be expenses over 8 additional quarters. On January 25, 2015 the company granted a total of 6,000,000
stock options (the "Options") to 3 Company officers who are also minority
owners and 1 employee. The Options, vest over 2 quarters and are exercisable
at a price of $0.10 per Share. The options were valued using the
Black-Scholes model with 241% volatility and 1.33% discount rate for a total
value of $429,679. $149,354 of this amount was expensed in Q1 2015, $209,094
in Q2 2015 and $71,230 in Q3 2015. On February 24, 2015 and March 31, 2015 the Company issued
1,900,000 restricted shares of common stock in consideration for investor
relations (IR) services provided to the Company. The shares were valued at
$114,600 based on the closing price of the Company's common stock on the date of
grant. On March 15, 2015 two note holders converted $145,886 of debt
and accrued interest to 2,917,698 shares at a conversion price of $0.05 per
share. The conversion occurred within the terms of the convertible note
agreements with no gain or loss recorded. On April 27, 2015 one share and warrant holders exercised
warrants for cash consideration of $110,000, in return 2,000,000 shares were
issued. On August 10, 2015 five note holders converted $103,150 of debt
and accrued interest to 8,251,963 shares at a conversion price of $0.0125 per
share. The conversion price per share was amended from $0.02 to $0.0125 by the
board of directors and a $60,182 loss was recorded related to the change in
conversion price. Following the change in conversion price the conversion
occurred within the terms of the amended agreement so no gain or loss was
recorded on the conversion. From November 25, 2015 through December 2, 2015, the Company
sold to 11 non-US private accredited investors, a total of 26,500,000 units for
cash consideration of $265,000 at a price of $0.01 (the "Units"), each unit
comprised of one share of common stock. Between November 10, 2015 and December 1, 2015 the Company
issued 10,800,000 restricted shares of common stock in consideration for
services provided to the Company. The shares were valued at $157,320 based on
the closing price of the Company's common stock on the date of grant. Share based payment transactions were accounted for in
accordance with the requirements of ASC 505-50 Equity Based Payments to Non
Employees. Paragraph 505-50-30-6 establishes that share-based payment
transactions with nonemployees shall be measured at the fair value of the
consideration received or the fair value of the equity instruments issued,
whichever is more reliably measurable. The Company measured share-based
payment transactions at the fair value of the shares issued at date of
grant, the Company believes that the value of the shares is more reliably
measurable. On March 1, 2012, the Company filed a Certificate of
Amendment to its Certificate of Incorporation effecting a forward stock
split of the Company's issued and outstanding shares of Common Stock at a
ratio of ten-to-one (the "Forward Split"). The Certificate of Amendment
provides that each outstanding share of the Company's Common Stock, par
value $0.0001 per share, will be split and converted, automatically, without
further action, into ten (10) shares of Common Stock of $0.00001 par value
per share. The Forward Split has been reflected in the Company's financial
statements for year ended December 31, 2013 and 2012. The Company believes that the issuances and sale of the
restricted shares were exempt from registration pursuant to Section 4(2) of
the Act as privately negotiated, isolated, non-recurring transactions not
involving any public solicitation. The recipients in each case represented
their intention to acquire the securities for investment only and not with a
view to the distribution thereof. Appropriate restrictive legends are
affixed to the stock certificates issued in such transactions. All
recipients of restricted shares either received adequate information about
the Company or had access, through employment, relation and/or business
relationships with the Company to such information. Purchases of
Equity Securities by the Issuer and Affiliated Purchases During the fourth quarter of the fiscal year ended December 31,
2015, neither we nor any "affiliated purchaser," as that term is defined in Rule
10b-18(a)(3) under the Exchange Act, repurchased any of our common stock or
other securities. During the years ended December 31, 2015 and 2014, the
Company issued the following restricted securities to "affiliated purchasers": During the period from February 19, 2014 to March 4, 2014, the
Company granted a total of 5,050,000 stock options (the "Options") to 4 Company
directors and officers who are also minatory owners. The Options, which are
fully vested, are exercisable at a price of $0.05 per Share. 1,400,000 options
were valued using the Black-Scholes model with 128% volatility and 2.17%
discount rate and 3,650,000 were valued using the Black-Scholes model with 154%
volatility and 2.17% discount rate for a total of $2,594,210. On January 23, 2014 to September 30, 2014 the Company sold to 1
non-US private accredited investor who is also an affiliated party 300,000
shares for total cash consideration of $30,000 at price of $0.10. On February 18, 2014 the Company issued to Dr. Oded Sagee
minority owner and founder of BreedIT Ltd., 2,200,000 shares of our common stock
valued based on the closing market price on the acquisition date at $151,800;
2,200,000 Class A options for the purchase of 2,200,000 shares of our common
stock at $0.055 per share valued using the black-scholes model with volatility
of 122% and a discount rate of 0.23% for a total value of $84,967; and 2,200,000
Class B options for the purchase of 2,200,000 shares of our common stock at
$0.065 per share valued using the black-scholes model with volatility of 122%
and a discount rate of 0.23% for a total value of $84,680. On April 14, 2014 1 share and warrant holder who is an affiliate
party exercised warrants for cash consideration of $110,000, in return 2,000,000
shares were issued. On October 2, 2014, 850,000 stock options (the "Options")
were granted to 1
Company officer who is also a minority owner. The Options, vest over 9 quarters
and are exercisable at a price of $0.05 per Share. The options were valued using
the Black-Scholes model with 281% volatility and 0.23% discount rate for a total
value of $152,955 with $52,185 expensed during Q4 2014 and $12,596 to be
expenses over 8 additional quarters. On December 1, 2015, the Company granted a total of 3,600,000
shares to Yaad Management and Consulting Ltd., a company controlled by Mr.
Itschak Shrem an officer and minority owner valued at $54,720. ITEM 6. SELECTED FINANCIAL DATA Back to Table of Contents None.
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITIONS AND RESULTS OF OPERATION Back to Table of Contents The following Management's Discussion and Analysis of
Financial Condition and Results of Operations ("MD&A") is intended to help
you understand our historical results of operations during the periods
presented and our financial condition. This MD&A should be read in
conjunction with our consolidated financial statements and the accompanying
notes to consolidated financial statements, and contains forward-looking
statements that involve risks and uncertainties. See section entitled
"Forward-Looking Statements" above. Executive Overview We are a company with limited operations and no significant
revenues from our business operations. There is substantial doubt that we can
continue as an on-going business for the next twelve months. We do not
anticipate that we will generate significant revenues until we enter into
licensing agreements with additional online gaming servers, or web advertisers,
to permit them to offer games of skill on our platform as part of their member
services, or as part of their advertising campaign. Accordingly, we must raise
cash from sources other than our operations in order to implement our marketing
plan. In our management's opinion, there is a potential demand for our
technology which will enable online game service providers, and websites engaged
in marketing efforts designed to increase traffic, to provide a platform
offering financial rewards to winners of online competitive games of skill. On July 10, 2011, we executed a license agreement with GT-SAT
International S.A.R.L ("GT-SAT"), a corporation organized under the laws of
Luxemburg. Such license agreement granted GT-SAT a non-exclusive right to
develop websites and offer online games based on our proprietary gaming platform
in Europe, with an exclusive license to develop websites and offer online games
based on our proprietary gaming platform in Luxembourg, Belgium, and
Holland. In consideration of such license, GT-SAT made an upfront,
non-refundable, payment of $90,000 and has agreed to pay us royalties on future
revenues. On December 26, 2011, GT-SAT terminated this agreement. The stated
reason for termination was the economic situation in Europe. On July 1, 2011, we executed a license agreement with Yanir
Levin Ltd., an Israeli corporation. Such license agreement granted the licensee
a non-exclusive right to develop websites and offer online games based on our
proprietary gaming platform in Asia, with an exclusive license to develop
websites and offer online games based on our proprietary gaming platform in
Israel. In consideration of the license granted to the licensee, the licensee
made an upfront, non refundable, payment of $29,000 and has agreed to pay us
royalties on future revenues. In April 2011, we raised $40,000 and issued 400,000 shares of
our common stock to two non-US investors. These transactions did not involve any
underwriters, underwriting discounts or commissions, nor any public
offering. We believe these transactions were exempt from registration pursuant
to Regulation S of the Securities Act. On August 19, 2013, we disclosed that we had entered into a
preliminary agreement (the "Preliminary Agreement") with BreedIT Israel and its
founder, Dr. Oded Sagee, pursuant to which we agreed to acquire 66.67% of
BreedIT Israel's capital stock. Subsequently, we were issued 200 shares of
BreedIT Israel's capital stock ("Ordinary Shares") which represent 66.67% of
BreedIT's outstanding Ordinary Shares with the founder, Dr. Oded Sagee owning
the remaining 100 Ordinary Shares, representing 33.33% of the outstanding
Ordinary Shares. In connection with the Preliminary Agreement, we agreed with Dr.
Sagee that prior to the execution of any definitive agreement, certain
conditions had to be satisfied, including, but not limited to: (i) completion of
due diligence reviews; (ii) obtaining requisite regulatory approvals; and (iii)
the execution of the binding agreement by and between BreedIT Israel and a
leading Israeli university granting BreedIT Israel the exclusive, world-wide
license for a unique and highly sophisticated decision making software used for
the purpose of advanced agriculture breeding (the "IDSS Software"). On October 21, 2013, we filed our Form 8-K report disclosing
that the Registrant, BreedIT Israel and Dr. Sagee executed the definitive Share
Purchase Agreement (the "SPA") which provided that we inject an initial
investment of US$245,000 (the "Initial Investment") which the parties agreed
should be sufficient to fund BreedIT Israel's operations during the ensuing
twelve-month period. The Registrant and BreedIT Israel further agreed that the
remaining US$755,000 of the US$1,000,000 investment amount be funded from time
to time, based upon BreedIT Israel's financial needs during the twelve-month
period. The closing of the SPA was subject to the execution of the binding
License Agreement between BreedIT Israel and the leading Israeli academic
institution (the "Licensor"), which closed on October 24, 2013. Consideration for the purchase was paid by us through issuance
of BreedIT Corp. Common Stock and Class A/B Options, the fair market value of
the Tangible/Intangible Assets acquired, as of the valuation date, was
determined to be $849,671 and the excess fair value of the assets over the fair
value of the identifiable assets owned at closing of $630,880 was booked as
goodwill. As the company is not generating income from the software sales and to
ensure the asset is carried at no more than the recoverable amount, $630,880 or
entire goodwill amount was impaired to expense during Q4 of 2013. On August 28, 2015, the Company entered into a separation
agreement with BreedIT Ltd., the Company's majority-owned subsidiary ("BreedIT
Israel"), BreedIT Israel's founder and minority stockholder, Dr. Oded Sagee
("Dr. Sagee") and Star Biotech Ltd, an Israeli company controlled by Dr. Sagee
("SB"). the Company and Dr. Sagee agreed to enter into the Separation Agreement
based upon the determination by the Company that it had fulfilled its
obligation to fund up to but not more than $1 million on behalf of BreedIT
Israel but was not willing to continue to fund BreedIT Israel as a result of the
financial condition and result of operations of BreedIT Israel and the estimate
of future revenues presented by Dr. Sagee. The company agreed that its Equity
Interest shall be diluted from sixty-six and two-thirds (66 2/3%) percent to
nineteen (19%) percent. SB shall have the option to acquire the company's shares
for the sum of $50,000 and in the event that the option is not exercised, SB
shall pay the Company an amount equal to ten (10%) percent of BreedIT Israel's
gross profits, for a period of three (3) years. On November 22, 2015 BreedIt entered into preliminary merger
agreement with Novomic Ltd. And Israeli company. On February 8, 2016 BreedIt
entered in a definitive material agreement for the merger which is expected to
close during Q2 2016. Results of Operations during the year ended December 31, 2015
as compared to the year ended December 31, 2014 During 2015 we generated revenues of $5,848 compared to revenues
of $5,824 during 2014. Our research and development expenses decreased to $0 during 2015
compared to $207,246 during the same period in the prior year. The decrease was
due to separation from our former subsidiary BreedIt Ltd. Our general and
administrative expenses during 2015 were $1,106,194 as compared to $4,139,929
during 2014. The significant decrease was due to separation from our former held
subsidiary BreedIt Ltd and decreased non-cash compensation. We incurred a net
loss of $1,179,097 attributable to BreedIT Corp during 2015 before discontinued
operations and $1,533,589 including discontinued operations, compared to a net
loss of $4,365,589 in 2014. Purchase or Sale of Equipment Other than the purchase of servers, work stations and relevant
literature, we do not expect to purchase or sell any plant or significant
equipment. Liquidity and Capital Resources Our balance sheet as of December 31, 2015 reflects assets of
$1,059,381 consisting of cash and cash equivalents of $356,037 certificates of
deposit of $640,418 and prepaid assets of 62,926. As of December 31, 2014
reflects assets of $1,788,625 consisting of cash and cash equivalents of
$1,041,960, certificates of deposit of $639,979, and assets held for sale of
$106,686. As of December 31, 2015, we had total current liabilities of
$2,804 consisting of deferred revenues. As of December 31, 2014, we had total current liabilities of
$389,536 consisting of $2,461 in accounts payable and accrued liabilities,
$40,910 accrued interest payable, $18,000 due to related parties, $5,800 in
deferred revenues, $201,000 in convertible notes payable, net of discount, and
$121,365 in liabilities, related to assets held for sale. As of December 31,
2014, we had $2,852 in long-term deferred revenues. We had positive working capital of $1,056,577 as of December 31,
2015 compared to positive working capital of $1,396,237 at December 31, 2014.
Such working capital has been sufficient to sustain our operations to date. Our
total liabilities as of December 31, 2015 were $2,804 compared to $392,388 at
December 31, 2014. During 2015, we used $1,029,288 in our operating activities.
This resulted from a net loss of $1,533,589, a gain of $6,780 on deconsolidation
of our former subsidiary, increase to other assets of $439,
increase in prepaid expenses of $62,926, decrease in accounts payable of
$272,166, decrease in related parties payables of $18,000 and decrease in
deferred revenues of $5,752 offset principally by $763,314 related to non-cash
compensation, $9,472 loss of JV, $60,182 loss on debt extinguishment, $30,207 decrease in accounts receivable and $7,126
increase in accrued liabilities. During 2014, we used $1,806,298 in our operating activities.
This resulted from a net loss of $4,565,330, increase to other assets of
$639,936, increase in accounts receivable of $30,270, decrease in deferred
revenues of $5,824 and offset principally by $3,195,525 related to non-cash
compensation, $128,192 amortization expenses related to debt discount, $89,597
increase in accounts payable and accrued liabilities, $3,736 loss on JV,
depreciation expense $2,317 and $15,695 increase related parties payable. During the year ended December 31, 2015, we used $33,493 from
decrease in cash from deconsolidation. During the year ended December 31, 2015, we financed our
negative cash flow from sale of common stock in the amount of $265,000, proceeds
from exercise of warrants in the amount of $110,000 and $13,020 from donated
capital from a related party. During the year ended December 31, 2014, we used $23,097 from
investing activities which resulted from $14,075 cash paid for investment and
$9,022 purchases of equipment. During the year ended December 31, 2014, we financed our
negative cash flow from sale of common stock in the amount of $2,040,900 and
proceeds from exercise of warrants in the amount of $239,500. While management of the Company believes that the Company will
be successful in its current and planned operating activities, there can be no
assurance that the Company will be successful in the achievement of sales of its
products that will generate sufficient revenues to earn a profit and sustain the
operations of the Company. Our ability to create sufficient working capital to sustain us
over the next twelve month period, and beyond, is dependent on our entering into
additional licensing agreement and on our success in issuing additional debt or
equity, or entering into strategic arrangement with a third party. There can be
no assurance that sufficient capital will be available to us. We currently have
no agreements, arrangements or understandings with any person to obtain funds
through bank loans, lines of credit or any other sources. Going Concern Consideration There is substantial doubt about our ability to continue as a
going concern. Our financial statements contain additional note disclosures with
respect to this matter. Off-Balance Sheet Arrangements We have no off-balance sheet arrangements. Critical Accounting Policies Our significant accounting policies are described in the notes to our
financial statements for the years ended December 31, 2015 and 2014, and are
included elsewhere in this annual report.
ITEM 7A.
QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
Back to Table of Contents We have not entered
into, and do not expect to enter into, financial instruments for trading or hedging
purposes.
ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA Back to Table of Contents
REPORT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors We have audited the accompanying balance sheets of BreedIt
Corp. as of December 31, 2015 and 2014 and the related statements of
operations, stockholders' deficit and cash flows for the years then ended.
These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these financial
statements based on our audits. We conducted our audits in accordance with standards of the
Public Company Accounting Oversight Board (United States). Those standards
require that we plan and perform the audits to obtain reasonable assurance
about whether the financial statements are free of material misstatement.
The Company is not required to have, nor were we engaged to perform, an
audit of its internal control over financial reporting. Our audits included
consideration of internal control over financial reporting as a basis for
designing audit procedures that are appropriate in the circumstances, but
not for the purpose of expressing an opinion on the effectiveness of the
Company's internal control over financial reporting. Accordingly, we express
no such opinion. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a reasonable
basis for our opinion. In our opinion, the financial statements referred to above
present fairly, in all material respects, the financial position of BreedIt
Corp. as of December 31, 2015 and 2014 and the results of its operations and
cash flows for the periods described above in conformity with accounting
principles generally accepted in the United States of America. The
accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. As discussed in Note 3 to the
financial statements, the Company suffered a net loss from operations and
has a net capital deficiency, which raises substantial doubt about its
ability to continue as a going concern. Management's plans regarding those
matters are also described in Note 3. The financial statements do not
include any adjustments that might result from the outcome of this
uncertainty. /s/ M&K CPAS, PLLC
$ 1,059,381 $ 1,788,625 $ $
2,461
2,804 5,800
-
18,000
-
40,910
-
201,000 - 121,365 2,804 389,536 - 2,852 2,804 392,388
1,446
921 (300) (300)
8,681,637
7,646,699 (7,795,853) (6,262,264) 1,056,577 1,396,237 $ 1,059,381 $ 1,788,625
December 31, 2015 December 31, 2014 Revenues $ 5,848 $ 5,824
-
(207,246) (1,106,194) (4,139,929) (1,106,194) (4,331,175) (1,100,346) (4,325,351)
-
- (17,379) (86,442) (78,751) (239,979) - - $ (1,179,097) $ (4,565,330) $ (1,179,097) $ (4,365,589) $ (1,533,589) $ (4,365,589) $ (0.01) $ (0.05) $ (0.00) $ 0.00 $ (0.01) $ (0.04) 105,073,765 87,665,395
December 31, 2015 December 31, 2014 (1,249,463) (4,571,238) $ (1,249,463) $ (4,371,497)
Additional Paid-in
72,255,917 723 $
2,015,172 $ 321,447 (300) $ (1,896,675)
(340) $
487,550 - - - - - (4,365,589) - (4,565,330) 92,049,512 921 7,646,699 169,647 (300) (6,262,264) (4,279) (154,187) 1,396,237 - - - - - (1,533,589) - (1,533,589)
144,419,173
1,446 $
8,681,637 $
169,647 (300) $ (7,795,853)
- $
1,056,577
Operating
Activities: $ (1,533,589) $ (4,565,330)
9,472
3,736
60,182 -
(6,780) -
(62,926) -
(272,166)
64,252
(18,000)
15,695 (5,752) (5,824) (1,029,288) (1,806,298)
- (9,022)
- (14,075) (33,493) - (33,493) (23,097) 13,020 - 388,020 2,280,400
(745,127)
445,097 1,101,164 656,067 $ 356,037 $ 1,101,164
BREEDIT CORP.
Note 1. Summary of Significant Accounting Policies Basis of Presentation
and Organization
BreedIt Corp. ("BreedIt" or the "Company") is a Delaware corporation and has
thus far very limited sales activity. The Company was incorporated under the
laws of the State of Delaware on May 26, 2010. On October 24, 2013 we
entered into an agreement to acquire 66.67% of BreedIT Israel's capital
stock. Subsequently, we were issued 200 shares of BreedIT Israel's capital
stock ("Ordinary Shares") which represent 66.67% of BreedIT's outstanding
Ordinary Shares with the founder, Dr. Oded Sagee owning the remaining 100
Ordinary Shares, representing 33.33% of the outstanding Ordinary Shares.
BreedIT Ltd. signed a binding agreement with a leading Israeli university
granting BreedIT Ltd. the exclusive, world-wide license for a unique and
highly sophisticated decision making software used for the purpose of
advanced agriculture breeding (the "IDSS Software"). The business plan of
the Company through its BreedIT Ltd subsidiary is to further develop and
market the IDSS Software system globally to the agricultural breeding
industry.
The accompanying financial statements of the Company were prepared from the
accounts of the Company under the accrual basis of accounting.
Cash and Cash Equivalents
For purposes of reporting within the statement of cash flows, the Company
considers all cash on hand, cash accounts not subject to withdrawal
restrictions or penalties, and all highly liquid debt instruments purchased
with a maturity of three months or less to be cash and cash equivalents. As
of December 31, 2015 and 2014, we had cash and cash equivalents of $356,037
and $1,041,960, respectively.
Certificate of Deposit
The certificates of deposit bear an interest rate of 0.02%, mature every 7
days and renew automatically at end of every period.
Discontinued Operations
The Company follows the policy of segregating the assets and liabilities of
subsidiaries or lines of business on its Balance Sheet from the assets
liabilities of continuing subsidiaries or lines of businesses when it is
decided to close or dispose of a subsidiary or line of business. The Company
also, follows the policy of separately disclosing the assets and liabilities
and the net operations of a subsidiary or line of business in its financial
statements when it is decided to close or dispose of a subsidiary or line of
business.
Revenue Recognition
The Company recognizes revenue from licensing its software to customers for
contractually defined periods of time. The Company recognizes revenue
ratably over the term of the contract in accordance with ASC 605 (1) when
the price is fixed and determinable, (2) persuasive evidence of an
arrangement exists, (3) delivery has occurred or services have been
provided, and (4) collectability is assured.
Loss Per Common Share
Basic loss per share is computed by dividing the net loss attributable to
the common stockholders by the weighted average number of shares of common
stock outstanding during the period. Fully diluted loss per share is
computed similar to basic loss per share except that the denominator is
increased to include the number of additional common shares that would have
been outstanding if the potential common shares had been issued and if the
additional common shares were dilutive.
Income Taxes
Income taxes are accounted for under the asset and liability method.
Deferred tax assets and liabilities are determined based on temporary
differences between the bases of certain assets and liabilities for income
tax and financial reporting purposes. The deferred tax assets and
liabilities are classified according to the financial statement
classification of the assets and liabilities generating the differences.
The Company maintains a valuation allowance with respect to deferred tax
assets. The Company establishes a valuation allowance based upon the
potential likelihood of realizing the deferred tax asset and taking into
consideration the Company's financial position and results of operations for
the current period. Future realization of the deferred tax benefit depends
on the existence of sufficient taxable income within the carryforward period
under the Federal tax laws.
Changes in circumstances, such as the Company generating taxable income,
could cause a change in judgment about the realizability of the related
deferred tax asset. Any change in the valuation allowance will be included
in income in the year of the change in estimate.
Fair Value of Financial Instruments
The Company estimates the fair value of financial instruments using the
available market information and valuation methods. Considerable judgment is
required in estimating fair value. Accordingly, the estimates of fair value
may not be indicative of the amounts the Company could realize in a current
market exchange. As of December 31, 2015 and 2014, the carrying value of
accounts payable and accrued liabilities approximated fair value due to the
short-term nature and maturity of these instruments.
Property and Equipment
Property and equipment are stated at cost, net of accumulated depreciation.
Depreciation is calculated by the straight-line method over the estimated
useful lives of the assets. The annual depreciation rates are as follows:
Computers and electronic equipment 33%
For the year ended December 31,
2015 and 2014 total additions to property and
equipment were $0 and $8,838, total accumulated depreciation is $0 and $2,912 and total
depreciation expense is $0 and $2,317, respectively.
Following is a summary of Property and Equipment, net for the years ended
December 31, 2015 and 2014. December 31, 2015
December 31, 2014 0 (2,912) $0 $6,873
Deferred Offering Costs
The Company defers as other assets the direct incremental costs of raising
capital until such time as the offering is completed. At the time of the
completion of the offering, the costs are charged against the capital
raised. Should the offering be terminated, deferred offering costs are
charged to operations during the period in which the offering is
terminated.
Impairment of Long-Lived Assets
The Company evaluates the recoverability of long-lived assets and the
related estimated remaining lives when events or circumstances lead
management to believe that the carrying value of an asset may not be
recoverable. As of December 31, 2015 and 2014, no events or circumstances occurred
for which an evaluation of the recoverability of long-lived assets was
required.
Estimates
The financial statements are prepared on the basis of accounting principles
generally accepted in the United States. The preparation of financial
statements in conformity with generally accepted accounting principles
requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities as of December 31, 2015 and 2014,
and expenses for the year ended December 31, 2015, and the periods from
inception to December 31, 2015. Actual results could differ from those
estimates made by management.
Impact of Recently Issued Accounting Standards
In September, 2015, the FASB issued ASU No. 2015-16, Business Combinations
(Topic 805) ("ASU 2015-16"). Topic 805 requires that an acquirer
retrospectively adjust provisional amounts recognized in a business
combination, during the measurement period. To simplify the accounting for
adjustments made to provisional amounts, the amendments in the Update
require that the acquirer recognize adjustments to provisional amounts that
are identified during the measurement period in the reporting period in
which the adjustment amount is determined. The acquirer is required to also
record, in the same period's financial statements, the effect on earnings of
changes in depreciation, amortization, or other income effects, if any, as a
result of the change to the provisional amounts, calculated as if the
accounting had been completed at the acquisition date. In addition an entity
is required to present separately on the face of the income statement or
disclose in the notes to the financial statements the portion of the amount
recorded in current-period earnings by line item that would have been
recorded in previous reporting periods if the adjustment to the provisional
amounts had been recognized as of the acquisition date. ASU 2015-16 is
effective for fiscal years beginning December 15, 2015. The adoption of ASU
2015-016 is not expected to have a material effect on the Company's
consolidated financial statements.
In August, 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts
with Customers (Topic 606): Deferral of the Effective Date ("ASU 2015-14").
The amendment in this ASU defers the effective date of ASU No. 2014-09 for
all entities for one year. Public business entities, certain not-for-profit
entities, and certain employee benefit plans should apply the guidance in
ASU 2014-09 to annual reporting periods beginning December 15, 2017,
including interim reporting periods within that reporting period. Earlier
application is permitted only as of annual reporting periods beginning after
December 31, 2016, including interim reporting periods with that reporting
period.
In April 2015, the Financial Accounting Standards Board ("FASB") issued
Accounting Standards Update ("ASU") No. 2015-03, Interest-Imputation of
Interest (Subtopic 835-30) ("ASU 2015-03"), which changes the presentation
of debt issuance costs in financial statements. ASU 2015-03 requires an
entity to present such costs in the balance sheet as a direct deduction from
the related debt liability rather than as an asset. Amortization of the
costs will continue to be reported as interest expense. It is effective for
annual reporting periods beginning after December 15, 2016. Early adoption
is permitted. The new guidance will be applied retrospectively to each prior
period presented. The Company is currently in the process of evaluating the
impact of adoption of ASU 2015-03 on its balance sheets.
On November 2014, The Financial Accounting Standards Board (FASB) issued
Accounting Standard Update No. 2014-16-Derivatives and Hedging (Topic 815):
Determining Whether the Host Contract in a Hybrid Financial Instrument
Issued in the Form of a Share Is More Akin to Debt or to Equity (a consensus
of the FASB Emerging Issues Task Force). The amendments in this Update do
not change the current criteria in GAAP for determining when separation of
certain embedded derivative features in a hybrid financial instrument is
required. That is, an entity will continue to evaluate whether the economic
characteristics and risks of the embedded derivative feature are clearly and
closely related to those of the host contract, among other relevant
criteria. The amendments clarify how current GAAP should be interpreted in
evaluating the economic characteristics and risks of a host contract in a
hybrid financial instrument that is issued in the form of a share. The
effects of initially adopting the amendments in this Update should be
applied on a modified retrospective basis to existing hybrid financial
instruments issued in the form of a share as of the beginning of the fiscal
year for which the amendments are effective. Retrospective application is
permitted to all relevant prior periods.
On November 2014, The Financial Accounting Standards Board (FASB) issued
Accounting Standard Update No. 2014-17-Business Combinations (Topic 805):
Pushdown Accounting (a consensus of the FASB Emerging Issues Task Force).
The amendments in this Update provide an acquired entity with an option to
apply pushdown accounting in its separate financial statements upon
occurrence of an event in which an acquirer obtains control of the acquired
entity. The amendments in this Update are effective on November 18, 2014.
After the effective date, an acquired entity can make an election to apply
the guidance to future change-in-control events or to its most recent
change-in-control event. However, if the financial statements for the period
in which the most recent change-in-control event occurred already have been
issued or made available to be issued, the application of this guidance
would be a change in accounting principle.
On August 2014, The Financial Accounting Standards Board (FASB) issued
Accounting Standard Update No. 2014-15, Presentation of Financial Statements
- Going Concerns (Subtopic 205-40): Disclosures of Uncertainties about an
Entity's Ability to Continue as a Going Concern. The amendments require
management to assess an entity's ability to continue as a going concern by
incorporating and expanding upon certain principles that are currently in
U.S. auditing standards. Specifically, the amendments (1) provide a
definition of the term substantial doubt, (2) require an evaluation every
reporting period including interim periods, (3) provide principles for
considering the mitigating effect of management's plans, (4) require certain
disclosures when substantial doubt is alleviated as a result of
consideration of management's plans, (5) require an express statement and
other disclosures when substantial doubt is not alleviated, and (6) require
an assessment for a period of one year after the date that the financial
statements are issued (or available to be issued). The amendments in this
Update are effective for the annual period ending after December 15, 2016,
and for annual periods and interim periods thereafter. Early application is
permitted.
In June 2014, the Financial Accounting Standards Board ("FASB") issued
Accounting Standards Update ("ASU") 2014-10, "Development Stage Entities".
The amendments in this update remove the definition of a development stage
entity from the Master Glossary of the ASC thereby removing the financial
reporting distinction between development stage entities and other reporting
entities from U.S. GAAP. In addition, the amendments eliminate the
requirements for development stage entities to (1) present inception-to-date
information in the statements of income, cash flows, and shareholder equity,
(2) label the financial statements as those of a development stage entity,
(3) disclose a description of the development stage activities in which the
entity is engaged, and (4) disclose in the first year in which the entity is
no longer a development stage entity that in prior years it had been in the
development stage. The amendments in this update are applied
retrospectively. The adoption of ASU 2014-10 removed the development stage
entity financial reporting requirements from the Company.
In June 2014, the Financial Accounting Standards Board (FASB) issued
Accounting Standards Update (ASU) No. 2014-12, Compensation - Stock
Compensation (Topic 718): Accounting for Share-Based Payments When the Terms
of an Award Provide That a Performance Target Could Be Achieved after the
Requisite Service Period. The new guidance requires that share-based
compensation that require a specific performance target to be achieved in
order for employees to become eligible to vest in the awards and that could
be achieved after an employee completes the requisite service period be
treated as a performance condition. As such, the performance target should
not be reflected in estimating the grant-date fair value of the award.
Compensation costs should be recognized in the period in which it becomes
probable that the performance target will be achieved and should represent
the compensation cost attributable to the period(s) for which the requisite
service has already been rendered. If the performance target becomes
probable of being achieved before the end of the requisite service period,
the remaining unrecognized compensation cost should be recognized
prospectively over the remaining requisite service period. The total amount
of compensation cost recognized during and after the requisite service
period should reflect the number of awards that are expected to vest and
should be adjusted to reflect those awards that ultimately vest. The
requisite service period ends when the employee can cease rendering service
and still be eligible to vest in the award if the performance target is
achieved. This new guidance is effective for fiscal years and interim
periods within those years beginning after December 15, 2015. Early adoption
is permitted. Entities may apply the amendments in this Update either (a)
prospectively to all awards granted or modified after the effective date or
(b) retrospectively to all awards with performance targets that are
outstanding as of the beginning of the earliest annual period presented in
the financial statements and to all new or modified awards thereafter. The
adoption of ASU 2014-12 is not expected to have a material impact on our
financial position or results of operations.
In June 2014, the FASB issued ASU No. 2014-10: Development Stage Entities
(Topic 915): Elimination of Certain Financial Reporting Requirements,
Including an Amendment to Variable Interest Entities Guidance in Topic 810,
Consolidation , to improve financial reporting by reducing the cost and
complexity associated with the incremental reporting requirements of
development stage entities. The amendments in this update remove all
incremental financial reporting requirements from U.S. GAAP for development
stage entities, thereby improving financial reporting by eliminating the
cost and complexity associated with providing that information. The
amendments in this Update also eliminate an exception provided to
development stage entities in Topic 810, Consolidation, for determining
whether an entity is a variable interest entity on the basis of the amount
of investment equity that is at risk. The amendments to eliminate that
exception simplify U.S. GAAP by reducing avoidable complexity in existing
accounting literature and improve the relevance of information provided to
financial statement users by requiring the application of the same
consolidation guidance by all reporting entities. The elimination of the
exception may change the consolidation analysis, consolidation decision, and
disclosure requirements for a reporting entity that has an interest in an
entity in the development stage. The amendments related to the elimination
of inception-to-date information and the other remaining disclosure
requirements of Topic 915 should be applied retrospectively except for the
clarification to Topic 275, which shall be applied prospectively. For public
companies, those amendments are effective for annual reporting periods
beginning after December 15, 2014, and interim periods therein. Early
adoption is permitted. The adoption of ASU 2014-10 is not expected to have a
material impact on our financial position or results of operations.
Note 2. Discontinued Operation and Deconsolidation of Held Subsidiary
The Company follows the policy of segregating the assets and liabilities of
subsidiaries or lines of business on its Balance Sheet from the assets
liabilities of continuing subsidiaries or lines of businesses when it is
decided to close or dispose of a subsidiary or line of business. The Company
also, follows the policy of separately disclosing the assets and liabilities
and the net operations of a subsidiary or line of business in its financial
statements when it is decided to close or dispose of a subsidiary or line of
business.
On August 28, 2015, the Company entered into a separation agreement with
BreedIT Ltd., the Company's majority-owned subsidiary ("BreedIT Israel"), in
which the company agreed that its Equity Interest shall be diluted from
sixty-six and two-thirds (66 2/3%) percent to nineteen (19%) percent.
Accordingly BreedIt Ltd. is no longer consolidated, a $6,780 gain was
recorded on deconsolidation and the remaining 19% of investment written off
during deconsolidation.
As a result of entering into the Separation Agreement, the operations of
BreedIt Ltd. have been classified as Discontinued Operations on the
Statement of Operations. The components of Discontinued Operations
summarized on the Statement of Operations arising from the decision to
separate from BreedIt Ltd. are as follows: December 31, 2015 December 31, 2014 Revenues $ 27,929 $ - (90,860)
(69,082) (293,912) (131,904) (384,772) (200,986) (356,843) (200,986) 2,351 1,245 - - $ (354,492) $ (199,741) - - - - $ - $ 106,686 - - - $ - $ 121,365
Note 3. Going Concern
The Company has limited operations. The business plan of the Company
transitioned from being a provider of online gaming software to the
developer and provider of an intelligent decision support system ("IDSS")
utilized by the agriculture breeding industry, we were able to utilize our
software programming expertise. Our business efforts are now being directed
toward offering our IDSS Software program to a wide variety of users engaged
in plant breeding, primarily within the seed industry. We plan on marketing
our IDSS Software to agro-breeders, providing them with the ability to
better plan, manage and analyze their breeding data and to perform research
activities quickly and effectively so as to significantly increase
production and plant quality. The accompanying financial statements have
been prepared in conformity with accounting principles generally accepted in
the United States of America, which contemplate continuation of the Company
as a going concern. The Company has not established any source of revenue to
cover its operating costs, and as such, has incurred an operating loss since
inception. These and other factors raise substantial doubt about the
Company's ability to continue as a going concern. The accompanying financial
statements do not include any adjustments to reflect the possible future
effects on the recoverability and classification of assets or the amounts
and classification of liabilities that may result from the possible
inability of the Company to continue as a going concern.
Note 4. Common Stock
On March 3, 2014 the Company issued 1,000,000 restricted shares of common
stock in consideration for investor relations (IR) services provided to the
Company. The shares were valued at $480,000 based on the closing price of
the Company's common stock on the date of grant.
From January 23, 2014 to September 30, 2014 the Company sold to 10 non-US
private accredited investors a total of 6,461,666 shares for cash
consideration of $923,000 at an average price of $0.143.
From March 10, 2014 through September 30, 2014, the Company sold to 12
non-US private accredited investors, a total of 3,270,000 units for cash
consideration of $667,750 at an average price of $0.204 (the "Units"), each
unit comprised of one share of common stock, one class C warrant with 24
months term exercisable at a price of $0.35; The relative fair value of the
stock with attached warrants was $189,300 for the common stock, $478,450 for
class C warrants.
On February 24, 2014 and March 13, 2014 3 share and warrant holders
exercised warrants and were issued 1,144,262 shares for cash consideration
of $48,000.
On February 18, 2014 the Company issued to Dr. Oded Sagee minority owner and
founder of BreedIT Ltd., 2,200,000 shares of our common stock valued based
on the closing market price on the acquisition date at $151,800; 2,200,000
Class A options for the purchase of 2,200,000 shares of our common stock at
$0.055 per share valued using the black-scholes model with volatility of
122% and a discount rate of 0.23% for a total value of $84,967; and
2,200,000 Class B options for the purchase of 2,200,000 shares of our common
stock at $0.065 per share valued using the black-scholes model with
volatility of 122% and a discount rate of 0.23% for a total value of
$84,680.
During the period from February 19, 2014 to March 4, 2014, the Company
granted a total of 5,050,000 stock options (the "Options") to 4 Company
directors and officers who are also minatory owners. The Options, which are
fully vested, are exercisable at a price of $0.05 per Share. 1,400,000
options were valued using the Black-Scholes model with 128% volatility and
2.17% discount rate and 3,650,000 were valued using the Black-Scholes model
with 154% volatility and 2.17% discount rate for a total of $2,594,210.
On March 12, 2014 the Company issued 30,000 warrants with term of 36 months,
exercisable at $0.60 per share to 1 entity in consideration for public
relations services provided to the company. The warrants were valued using
the Black-Scholes model with 117% volatility and 0.22% discount rate for a
total of $16,134.
On April 1, 2014 and April 7, 2014 the Company sold to 2 private accredited
investors, a total of 1,215,000 units for cash consideration of $250,150 at
an average price of $0.206 (the "Units"), each unit comprised of one share
of common stock, one class C warrant with 24 months term exercisable at a
price of $0.35; The relative fair value of the stock with attached warrants
was $61,984 for the common stock, $188,166 for class C warrants.
On May 8, 2014 the Company sold to 1 private accredited investor, a total of
666,667 units for cash consideration of $200,000 at a price of $0.30 (the
"Units"), each unit comprised of one share of common stock, one class H
warrant with 3 months term exercisable at a price of $0.30 and one class I
warrant with 18 month term exercisable at price of $0.45; The relative fair
value of the stock with attached warrants was $69,916 for the common stock,
$130,085 for warrants.
On April 12, 2014 the Company issued 1,000,000 warrants, vesting over 12
quarters in equal amounts starting July 1, 2014 with term of 36 months from
vesting date, exercisable at $0.35 per share to 1 entity in consideration
for serving on the company's scientific advisory board. The warrants were
valued using the Black-Scholes model with 284% volatility and 1.10% discount
rate for a total of $71,885 of this amount $26,957 was expensed during the
quarter with balance to be expensed over the remaining term.
On April 14, 2014 and on June 22, 2014 2 share and warrant holders exercised
warrants for cash consideration of $140,000, in return 2,600,000 shares were
issued.
During Q2 2014 one shareholder converted $4,000 of debt and accrued interest
to 200,000 shares at a conversion price of $0.02 per share. The conversion
occurred within the terms of the convertible note agreements with no gain or
loss recorded.
Between September 9, 2014 and October 1, 2014 2 share and warrant holders
exercised warrants for cash consideration of $51,500, in return 900,000
shares were issued.
On August 17, 2014 and October 28, 2014 the Company issued 136,000
restricted shares of common stock in consideration for investor relations (IR)
services provided to the Company. The shares were valued at $26,040 based on
the closing price of the Company's common stock on the date of grant.
On October 2, 2014 850,000 stock options (the "Options") to 1 Company
officer who is also minority owners. The Options, vest over 9 quarters and
are exercisable at a price of $0.05 per Share. The options were valued using
the Black-Scholes model with 281% volatility and 0.23% discount rate for a
total value of $152,955 with $52,185 expensed during Q4 2014 and $12,596 to
be expenses over 8 additional quarters.
On January 25, 2015 the company granted a total of 6,000,000 stock options
(the "Options") to 3 Company officers who are also minority owners and 1
employee. The Options, vest over 2 quarters and are exercisable at a price
of $0.10 per Share. The options were valued using the Black-Scholes model
with 241% volatility and 1.33% discount rate for a total value of $429,679.
$149,354 of this amount was expensed in Q1 2015, $209,094 in Q2 2015 and
$71,230 in Q3 2015.
On February 24, 2015 and March 31, 2015 the Company issued 1,900,000
restricted shares of common stock in consideration for investor relations (IR)
services provided to the Company. The shares were valued at $114,600 based
on the closing price of the Company's common stock on the date of grant.
On March 15, 2015 two note holders converted $145,886 of debt and accrued
interest to 2,917,698 shares at a conversion price of $0.05 per share. The
conversion occurred within the terms of the convertible note agreements with
no gain or loss recorded.
On April 27, 2015 one share and warrant holders exercised warrants for cash
consideration of $110,000, in return 2,000,000 shares were issued.
On August 10, 2015 five note holders converted $103,150 of debt and accrued
interest to 8,251,963 shares at a conversion price of $0.0125 per share. The
conversion price per share was amended from $0.02 to $0.0125 by the board of
directors and a $60,182 loss was recorded related to the change in
conversion price. Following the change in conversion price the conversion
occurred within the terms of the amended agreement so no gain or loss was
recorded on the conversion.
From November 25, 2015 through December 2, 2015, the Company sold to 11
non-US private accredited investors, a total of 26,500,000 units for cash
consideration of $265,000 at a price of $0.01 (the "Units"), each unit
comprised of one share of common stock.
Between November 10, 2015 and December 1, 2015 the Company issued 10,800,000
restricted shares of common stock in consideration for services provided to
the Company. The shares were valued at $157,320 based on the closing price
of the Company's common stock on the date of grant.
Share based payment transactions were accounted for in accordance with the
requirements of ASC 505-50 Equity Based Payments to Non Employees. Paragraph
505-50-30-6 establishes that share-based payment transactions with
nonemployees shall be measured at the fair value of the consideration
received or the fair value of the equity instruments issued, whichever is
more reliably measurable. The Company measured share-based payment
transactions at the fair value of the shares issued at date of grant, the
Company believes that the value of the shares is more reliably measurable.
On March 1, 2012, the Company filed a Certificate of Amendment to its
Certificate of Incorporation effecting a forward stock split of the
Company's issued and outstanding shares of Common Stock at a ratio of
ten-to-one (the "Forward Split"). The Certificate of Amendment provides
that each outstanding share of the Company's Common Stock, par value $0.0001
per share, will be split and converted, automatically, without further
action, into ten (10) shares of Common Stock of $0.00001 par value per
share. The Forward Split has been reflected in the Company's financial
statements for year ended December 31, 2015 and 2014.
Following is a table of warrant and options still outstanding and
exercisable along with exercise price and range of remaining term.
Note 5. Revenue Recognition
On July 1 2011 and on July 10, 2011, the Company signed license agreements
with two separate corporations in Israel and Luxemburg (the "Licensees").
Subject to the terms and condition of each agreement the Company granted
each Licensee a license to use the Company's proprietary online gaming
platform in certain parts of the world. Each license is, in general,
non-exclusive, except for certain countries specified within each
agreement. The agreements grant each Licensee the right to develop and
operate websites offering online games based on the Company's proprietary
technology for a period of 5 years as of the respective agreement's
effective date. In the event that by the eighteenth-month anniversary of the
each agreement's effective date the respective Licensee fails to have at
least one active website in each of the countries that comprise the
exclusive territory of the agreement, the Company shall be entitled to
either terminate exclusivity for these countries or terminate the entire
agreement. In consideration of these agreements, and of support services to
be provided by the Company through the license period, the Licensees have
paid the Company non-refundable, one-time license fees totaling $119,000. In
addition to such license fees, once each Licensee realizes revenues at
a certain level specified in its respective agreement from its use of the
Company's platform, it shall pay the Company a royalty in the amount of 50%
of gross revenues realized from its use of this platform.
On December 26, 2011, the corporation from Luxemburg announced the
termination of the agreement due to the economic situation in Europe. As a
result, the entire license fee in the amount of $90,000 was recognized
immediately as revenues.
As of December 31, 2015 and 2014, the Company recognized a total sum of
$5,848 and $5,824, respectively, in revenues out of the total $119,000
license fees paid for both of the aforementioned agreements. The contract in
the amount of $90,000 was canceled by the client; therefore we recognized
the whole sum as revenues according to the terms of the agreement. The
second contract grants the client licenses for a period of 5 years,
accordingly $5,848 was recorded as revenues 2015 and $5,824 in 2014; the
remaining sum of $2,804 was deferred on the Company's balance sheet as
current and is expected to be recognized over the remaining period of the
agreements.
As of December 31, 2015 and 2014, no royalties have been paid by or
recognized in connection with the aforementioned agreements.
One of the aforementioned Licensees is beneficially owned by an individual
who holds 25,000 shares of the Company's common stock.
Note 6. Income Taxes
The provision (benefit) for income taxes for the year ended December 31,
2015 and 2014, was as follows (assuming a 35% effective tax rate): 2015 2014 - - - - 903,842 655,137 (903,842) (655,137) - -
The Company had deferred income tax assets as of December 31, 2015 and 2014,
as follows: 2015 2014 903,842 655,137 (903,842) (655,137) - -
The Company provided a valuation allowance equal to the deferred income tax
assets for the year ended December 31, 2015 and 2014, because it is not
presently known whether future taxable income will be sufficient to utilize
the loss carryforwards.
As of December 31, 2015 and 2014, the Company had approximately
$2,582,407
and $1,871,820 respectively, in tax loss carryforwards that can be utilized
in future periods to reduce taxable income, and expire by the year 2030.
The Company did not identify any material uncertain tax positions that will
be filed. The Company did not recognize any interest or penalties for
unrecognized tax benefits during the year ended December 31, 2015 and 2014.
The Company will file income tax returns in the United States. All tax years
are closed by expiration of the statute of limitations. The year ended
December 31, 2015 and 2014.
Note 7. Related Party Transactions
During the period from February 19, 2014 to March 4, 2014, the Company
granted a total of 5,050,000 stock options (the "Options") to 4 Company
directors and officers who are also minatory owners. The Options, which are
fully vested, are exercisable at a price of $0.05 per Share. 1,400,000
options were valued using the Black-Scholes model with 128% volatility and
2.17% discount rate and 3,650,000 were valued using the Black-Scholes model
with 154% volatility and 2.17% discount rate for a total of $2,594,210.
On January 23, 2014 to September 30, 2014 the Company sold to 1 non-US
private accredited investor who is also an affiliated party 300,000 shares
for total cash consideration of $30,000 at price of $10 per share.
On February 18, 2014 the Company issued to Dr. Oded Sagee minority owner and
founder of BreedIT Ltd., 2,200,000 shares of our common stock valued based
on the closing market price on the acquisition date at $151,800; 2,200,000
Class A options for the purchase of 2,200,000 shares of our common stock at
$0.055 per share valued using the black-scholes model with volatility of
122% and a discount rate of 0.23% for a total value of $84,967; and
2,200,000 Class B options for the purchase of 2,200,000 shares of our common
stock at $0.065 per share valued using the black-scholes model with
volatility of 122% and a discount rate of 0.23% for a total value of
$84,680.
On April 14, 2014 1 share and warrant holder who is an affiliate party
exercised warrants for cash consideration of $110,000, in return 2,000,000
shares were issued.
On October 2, 2014 850,000 stock options (the "Options") to 1 Company
officer who is also a minority owner. The Options, vest over 9 quarters and
are exercisable at a price of $0.05 per Share. The options were valued using
the Black-Scholes model with 281% volatility and 0.23% discount rate for a
total value of $152,955 with $52,185 expensed during Q4 2014 and $12,596 to
be expenses over 8 additional quarters.
As of December 31, 2014 the Company has $18,000 in fees due and payable,
$9,000 payable to one advisory board member and $9,000 payable to one Board
of director members for services rendered in 2014.
On January 25, 2015 the company granted a total of 6,000,000 stock options
(the "Options") to 3 Company officers who are also minority owners and 1
employee. The Options, vest over 2 quarters and are exercisable at a price
of $0.10 per Share. The options were valued using the Black-Scholes model
with 241% volatility and 1.33% discount rate for a total value of $429,679
with $429,629 expensed during the twelve months ended December 31, 2015.
On November 30, 2015 the Company issued 3,600,000 restricted shares of
common stock in consideration for services provided to the Company to a
related party. The shares were valued at $60,000 based on the closing price
of the Company's common stock on the date of grant.
Note 8. Convertible and Non-Convertible Notes Payable
During the year ended December 31, 2015 two note holders converted $145,886
of debt and accrued interest to 2,917,698 shares at a conversion price of
$0.05 per share. The conversion occurred within the terms of the convertible
note agreements with no gain or loss recorded. In addition five note holders
converted $103,150 of debt and accrued interest to 8,251,963 shares at a
conversion price of $0.0125 per share. The conversion price per share was
amended from $0.02 to $0.0125 by the board of directors and a $60,182 loss
was recorded related to the change in conversion price. Following the change
in conversion price the conversion occurred within the terms of the amended
agreement so no gain or loss was recorded on the conversion.
During the year ended December 31, 2014, a convertible note of $3,200 along
with $800 of accrued interest was converted to 200,000 shares of common
stock at $0.02 per share. The conversion occurred within the terms of the
convertible note agreement with no gain or loss recorded on the conversion.
The Company recorded amortization expenses related to the beneficial
conversion features of $0 and $128,192 during the years ended December 31,
2015 and December 31, 2014 respectively. Remaining debt discount as of
December 31, 2015 and 2014 is $0 and $0, respectively.
The Company recorded interest expense in the amount of $7,970 and $25,345
during the years ended December 31, 2015 and December 31, 2014, respectively.
Note 9. Subsequent Events
As defined in FASB ASC 855-10, "Subsequent Events", subsequent events are
events or transactions that occur after the balance sheet date but before
financial statements are issued or available to be issued.
During Q1 2016, the Company signed a merger agreement with Novomic Ltd., the
merger is expected to close during Q2 2016.
The Company evaluated all other events and transactions that occurred
subsequent to the balance sheet date and prior to the date on which the
financial statements contained in this report were issued, and the Company
determined that no such events or transactions necessitated disclosure.
None. ITEM 9 A. CONTROLS AND
PROCEDURES Back to Table of Contents Evaluation of Disclosure Controls and Procedures
As of December 31, 2015, the Company's chief executive officer and chief
financial officer conducted an evaluation regarding the effectiveness of the
Company's disclosure controls and procedures (as defined in Rules 13a-15(e)
or 15d-15(e) under the Exchange Act. Based upon the evaluation of these
controls and procedures, our chief executive officer/chief financial officer
concluded that our disclosure controls and procedures were not effective as
of the end of the fiscal year 2015. Management's Annual Report on
Internal Control over Financial Reporting Management is
responsible for establishing and maintaining adequate internal control over
financial reporting and for the assessment of the effectiveness of those
internal controls. As defined by the SEC, internal control over financial
reporting is a process designed by our principal executive officer and
principal financial officer, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of the financial
statements in accordance with U.S. generally accepted accounting principles. Because of its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements. Also, projections of any
evaluation of effectiveness to future periods are subject to the risk that
controls may become inadequate because of changes in conditions, or that the
degree of compliance with the policies or procedures may deteriorate.
Management has assessed the effectiveness of our internal control over
financial reporting as of December 31, 2015. In making this assessment,
management used the criteria set forth by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO) in Internal
Control-Integrated Framework. Based on our assessment and those criteria, we
have concluded that our internal control over financial reporting had
material weaknesses including lack of sufficient internal accounting
personnel in order to ensure complete documentation of complex transactions
and adequate financial reporting during the year ended December 31, 2015.
Management has identified corrective actions for the weakness and has begun
implementation during the second quarter of 2016. This annual report
does not include an attestation report of the Company's registered public
accounting firm regarding internal control over financial reporting.
Management's report was not subject to attestation by the Company's
registered public accounting firm pursuant to temporary rules of the
Securities and Exchange Commission that permit the Company to provide only
Management's report in this annual report. Changes in Internal
Control over Financial Reporting There were no changes in our
internal control over financial reporting or in other factors identified in
connection with the evaluation required by paragraph (d) of Exchange Act
Rules 13a-15 or 15d-15 that occurred during the fourth quarter ended
December 31, 2015 that have materially affected, or are reasonably likely to
materially affect, our internal control over financial reporting.
ITEM 9B. OTHER INFORMATION Back to Table of Contents None.
PART III
As of
April 4, 2016, there were 44 registered stockholders holding 144,419,173 common
shares.
Dividends
Since our inception, we have not declared
nor paid any cash dividends on our capital stock and we do not anticipate paying
any cash dividends in the foreseeable future. Our current policy is to retain
any earnings in order to finance our operations. Our Board of directors will
determine future declarations and payments of dividends, if any, in light of the
then-current conditions it deems relevant and in accordance with applicable
corporate law.
Securities Authorized for Issuance under Equity
Compensation Plans
As of year-end, the employees stock option plan
was suspended due to the separation agreement from BreedIt Ltd.
Recent Sales of Unregistered Securities; Use of Proceeds
from Sale of Registered Securities
On February 18, 2014 the Company issued to
Dr. Oded Sagee minority owner and founder of BreedIT Ltd., 2,200,000 shares
of our common stock valued based on the closing market price on the
acquisition date at $151,800; 2,200,000 Class A options for the purchase of
2,200,000 shares of our common stock at $0.055 per share valued using the
black-scholes model with volatility of 122% and a discount rate of 0.23% for
a total value of $84,967; and 2,200,000 Class B options for the purchase of
2,200,000 shares of our common stock at $0.065 per share valued using the
black-scholes model with volatility of 122% and a discount rate of 0.23% for
a total value of $84,680.
On May 8, 2014 the Company sold to 1 private
accredited investor, a total of 666,667 units for cash consideration of
$200,001 at a price of $0.30 (the "Units"), each unit comprised of one share
of common stock, one class H warrant with 3 months term exercisable at a
price of $0.30 and one class I warrant with 18 month term exercisable at
price of $0.45; The relative fair value of the stock with attached warrants
was $69,916 for the common stock, $130,085 for warrants.
On April 12,
2014 the Company issued 1,000,000 warrants, vesting over 12 quarters in
equal amounts starting July 1, 2014 with term of 36 months from vesting
date, exercisable at $0.35 per share to 1 entity in consideration for
serving on the company's scientific advisory board. The warrants were valued
using the Black-Scholes model with 284% volatility and 1.10% discount rate
for a total of $71,885 of this amount $26,957 was expensed during the year
with balance to be expensed over the remaining term.
On April 14,
2014 and on June 22, 2014 2 share and warrant holders exercised warrants for
cash consideration of $140,000, in return 2,600,000 shares were issued.
During Q2 2014 one shareholder converted $4,000 of debt and accrued
interest to 200,000 shares at a conversion price of $0.02 per share. The
conversion occurred within the terms of the convertible note agreements with
no gain or loss recorded.
Between September 9, 2014 and October 1,
2014 2 share and warrant holders exercised warrants for cash consideration
of $51,500, in return 900,000 shares were issued.
On August 17, 2014
and October 28, 2014 the Company issued 136,000 restricted shares of common
stock in consideration for investor relations (IR) services provided to the
Company. The shares were valued at $26,040 based on the closing price of the
Company's common stock on the date of grant.
Report of Independent
Registered Public Accounting Firm
14
Financial Statements for the Years Ended December 31, 2015 and 2014
Balance Sheets
15
Statements
of Operations
16
Statements
of Comprehensive Income (Loss)
17
Statement of Stockholders' Deficit
18
Statements
of Cash Flows
19
Notes to
Financial Statements
20
Back to
Table of Contents
BreedIt Corp.
Tel Aviv, Israel
www.mkacpas.com
Houston, Texas
April 4, 201
BREEDIT CORP.
(Formerly
Progaming Platforms Corp.)
Balance Sheets
As of December 31, 2015 and 2014
Back to
Table of Contents
December
31, 2015
December
31, 2014
Assets
Current assets:
Cash and cash equivalents
$
356,037
$
1,041,960
Certificate of deposit
640,418
639,979
Prepaid assets
62,926
-
Assets held for sale
-
106,686
Total assets
Liabilities
and Stockholders' Equity (Deficit)
Current liabilities:
Accounts payable
and accrued liabilities
-
Deferred revenues
Related parties
payable
Accrued interest
payable
Convertible notes payable, net of
discount
Liabilities, related to assets held for sale
Total
current liabilities
Long-term
deferred revenues
Total liabilities
Stockholders' equity
(deficit)
Common stock, par
value $0.0001 per share, 500,000,000 shares authorized:
144,419,173 and 92,049,512 shares issued and outstanding at December 31,
2015 and 2014, respectively
Stock payable
169,647
169,647
Stock subscription
receivable
Accumulated other
comprehensive loss
-
(4,279)
Non-controlling
interest
-
(154,187)
Additional paid-in
capital
Accumulated
deficit
Total stockholders' equity (deficit)
Total liabilities and
stockholders' equity (deficit)
The accompanying notes are an integral part of these financial statements.
BREEDIT CORP.
(Formerly
Progaming Platforms Corp.)
Statements of Operations
For
the Years December 31, 2015 and 2014
Back to
Table of Contents
For the year ended
For the year ended
Expenses
Research and development
General and administrative
Total operating expenses
(Loss) from operations
Interest expense
(7,970)
(153,537)
Loss on
extinguishment of debt
(60,182)
Gain on
deconsolidation
6,780
Other income (expense)
Foreign currency translation
gain/(loss)
Provision for
income taxes
Net loss
from continuing operations
Less: loss
attributable to non-controlling interest
-
199,741
Net loss
attributable to BreedIT Corp. continuing operations
Net loss
from discontinued operations
(354,492)
-
Net loss
Net loss per common share -
basic and diluted - continuing operations
Net loss per common share -
basic and diluted - discontinued operations
Net loss per common share -
basic and diluted
Weighted average number of
common shares outstanding - basic
The accompanying
notes are an integral part of these financial statements.
BREEDIT CORP.
(Formerly
Progaming Platforms Corp.)
Statements of Comprehensive Income (Loss)
For
the Years December 31, 2015 and 2014
Back to
Table of Contents
For the year ended
For the year ended
Net loss
from continuing operations
(1,179,097)
(4,565,330)
Change in
unrealized foreign currency
translation gain (loss)
(70,366)
(5,908)
Total comprehensive loss continuing
operations
Less:
comprehensive loss attributable to non-controlling interest
-
199,741
Comprehensive loss attributable to BreedIT Corp.
continuing operations
The accompanying
notes are an integral part of these financial statements.
BREEDIT CORP.
(Formerly Progaming Platforms Corp.)
Statement of Changes in Stockholders' Equity
For
the Years December 31, 2015 and 2014
Back to
Table of Contents
Stock
Stock
Total
Common
Subscription
Subscription
Accumulated
Stockholders'
Shares
Amount
Capital
Payable
Receivable
Deficit
OCI
NCI
Equity
Balance
as of December 31, 2013
47,523
Shares issued for cash
11,613,333
116
2,040,784
-
-
-
-
-
2,040,900
Debt converted payable
converted to shares
200,000
2
3,998
-
-
-
-
-
4,000
Options issued to
employees
-
-
2,646,394
-
-
-
-
-
2,646,394
Warrants issued for
services
-
-
43,091
-
-
-
-
-
43,091
Warrants exercised
4,644,262
46
239,454
-
-
-
-
-
239,500
Shares issued for services
1,136,000
12
506,028
-
-
-
-
-
506,040
Debt discount
-
-
-
-
-
-
-
-
-
Acquisition of BreedIT
subsidiary 66.67%
2,200,000
22
151,778
(151,800)
-
-
-
-
-
Foreign currency
adjustment
-
-
-
-
-
-
(3,939)
(1,969)
(5,908)
Net
loss for the year
(199,741)
Balance as of December 31, 2014
Loss on debt extinguishment
-
-
60,182
-
-
-
-
-
60,182
BreedIT Ltd. deconsolidation
-
-
(425,089)
-
-
-
51,190
354,888
(19,011)
Shares issued for cash
26,500,000
265
264,735
-
-
-
-
-
265,000
Debt converted into shares
11,169,661
112
248,924
-
-
-
-
-
249,036
Options issued to employees
-
-
478,658
-
-
-
-
-
478,658
Warrants issued for services
-
-
12,735
-
-
-
-
-
12,735
Warrants exercised for cash
2,000,000
20
109,980
-
-
-
-
-
110,000
Shares issued for services
12,700,000
128
271,793
-
-
-
-
-
271,921
Donated
capital
-
-
13,020
-
-
-
-
-
13,020
Foreign currency
adjustment
-
-
-
-
-
-
(46,911)
(200,701)
(247,612)
Net
loss for the year
-
Balance
as of December 31, 2015
-
The accompanying
notes are an integral part of these financial statements.
BREEDIT CORP.
(Formerly
Progaming Platforms Corp.)
Statements of Cash Flows
For
the Years Ended December 31, 2015 and 2014
Back to
Table of Contents
For
the Year Ended
For
the Year Ended
December 31, 2015
December 31, 2014
Net loss
Adjustments to reconcile net
(loss) to net cash (used in) operating activities:
Amortization of
debt discount
-
128,192
Loss on JV
Loss on debt extinguishment
Gain on deconsolidation
Options issued for services
478,658
2,646,394
Warrants issued for
services
12,735
43,091
Shares issued for
services
271,921
506,040
Depreciation
expense
-
2,317
Changes in net assets and
liabilities:
Decrease (increase)
in accounts receivable
30,270
(30,270)
Decrease (increase)
in other current assets
(439)
(639,936)
Decrease (increase)
in prepaid expenses
(Decrease) increase
in accounts payable
(Decrease) increase
in related parties payable
(Decrease) increase
in accrued expenses
7,126
25,345
(Decrease) increase in deferred
revenue
Net cash used in operating
activities
Investing activities:
Cash paid for investment
Purchases of
property and equipment
Decrease in cash from deconsolidation
Net cash used in investing
activities
Financing activities:
Proceeds from
exercise of warrants
110,000
239,500
Proceeds
from sale of stock
265,000
2,040,900
Donated capital - related party
Net cash provided by
financing activities
Foreign
currency adjustment
(70,366)
(5,908)
Net increase (decrease)
in cash
Cash and cash equivalents
-
beginning of period
Cash and cash equivalents
-
end of period
Non cash transactions:
Conversion of
convertible note payable and accrued interest to common stock
$
249,036
$
4,000
Shares issued from
stock payable
$
-
$
151,800
Additional information:
Cash paid for
interest expenses
$
-
$
-
Cash paid for
income taxes
$
-
$
-
The accompanying
notes are an integral part of these financial statements.
(formerly Progaming Platforms Corp.)
Notes to Financial Statements
December 31, 2015
Back to
Table of Contents
Computers
$0
$9,785
Accumulated
depreciation
Property and
Equipment, net
For the year ended
For the year ended
Expenses
Research and development
General and administrative
Total operating expenses
(Loss) from operations
Other income (expense)
Provision for
income taxes
Net loss
Assets:
Cash
$
$
59,204
Investment accounted for using equity method
10,339
Property and equipment, net
6,873
Other receivables
30,270
Total assets held for sale
Liabilities:
Accounts payable
36,890
Accrued expenses
-
84,475
Other current liabilities
Total
liabilities related to assets held for sale
Type
Quantity
Exercise Price
Term
Warrants Class B
2,200,000
$0.065
1-3 Months
Warrants Class C
1,395,000
$0.35
1-3 Months
Warrants Class I
666,667
$0.45
1-12 Months
Total
4,261,667
Current
tax provision:
Federal
Taxable
income
$
$
Total
current tax provision
$
$
Deferred
tax provision
Federal
Loss
carryforwards
$
$
Change
in valuation allowance
$
$
Loss
carryforwards
$
$
Less-
Valuation allowance
Total
net deferred tax assets
$
$
Our directors hold office until the next annual general meeting of the stockholders or until their successors are elected and qualified. Our officers are appointed by our Board of Directors and hold office until the earlier of their death, retirement, resignation, or removal.
The following table sets forth the names and ages of the members of our Board of Directors and our executive officers and the positions held by each.
Name | Age |
Title | ||
Itschak Shrem | 68 |
CEO and Chairmanr | ||
Oded Gilboa | 42 |
CFO | ||
Erez Zino |
43 |
Director |
Itschak Shrem, 68, CEO and Chairman. Mr. Shrem, is an entrepreneur with over twenty-five years of professional business experience in the fields of investment banking, venture capital, finance, insurance and technology, among others, involving both public and private entities.
From 1995 to the present, Mr. Shrem has served as Managing director of Yaad Consulting 1995 Ltd., which was organized in 1995 and provides business development, marketing and investment banking services to a wide variety of Israeli companies. Mr. Shrem has held several positions with S R Accord Ltd. (formerly, The Shrem Fudim Group Ltd): from April 1991 until December 1999, Mr. Shrem served as Vice Chairman; from December 1999 until June 2013 Mr. Shrem served as a chairman of the board; and from June 2013 to present, he as served as a member of the board of directors. S R Accord was founded by Mr. Shrem in 1991, is listed on the Tel-Aviv Stock Exchange ("TASE") and is engaged in investment banking in Israel. From 1991 to 2010, Mr. Shrem served as the Chairman of Leader Holdings and Investments Ltd. and Polar Communications Ltd., both TASE-listed companies engaged in investment banking and venture capital, the latter of which specializes in the media and telecommunications industries. From 2007 until 2012, Mr. Shrem served as a director of Retalix, (NASDAQ:RTLX). In 1993, Mr. Shrem founded Pitango Venture Capital Fund, which has investments in over 120 companies, principally in the technology industry and presently has approximately $1.5 billion under management. Mr. Shrem presently holds positions as partner in the GP of Pitango I, II and III. Since October 2010, Mr. Shrem has served as an independent director of Eden Springs Ltd, TASE-listed Company and a leading Israeli mineral water company with operations, through a subsidiary, in 16 countries throughout Europe. Mr. Shrem spent over 15 years with Clal Israel Ltd, serving in various capacities including Chief Operating Officer, responsible for Clal's capital markets and insurance businesses until March, 1991. Mr. Shrem holds a B.A. in Economics from Bar-Ilan University, Israel, and an M.B.A. from Tel-Aviv University, Israel.
Oded Gilboa, 42, was appointed to be the Company's CFO on December 4, 2013. He is a licensed CPA in the United States and Israel. Prior to his appointment as CFO, Mr. Gilboa served as the Registrant's finance and accounting consultant. Mr. Gilboa has over 16 years of experience in finance and public accounting, having served as a senior finance executive in the technology and biotech industries with responsibilities in corporate finance, accounting, strategic planning and operational and financial management. From 2010 through 2012, Mr. Gilboa served as the Revenue Accounting and Finance Manager of Mylan Specialty, a subsidiary of Mylan Inc. (NASDAQ: MYL), a global company focused on the development, manufacturing and marketing of prescription drug products. From 2007 through 2009, Mr. Gilboa was the Executive director of Finance and US Controller of Taro Pharmaceuticals (NASDAQ:TAROF), a global pharmaceutical company. From 1998 through 2007 Mr. Gilboa held various financial positions with IDT Corporation (NYSE:IDT), a world-wide provider of telecommunications and media services, where in his most recent role he served as director of Finance. Mr. Gilboa Mr. Gilboa began his career in public accounting, auditing both public and private companies and holds a B.A in Economics and Accounting from Tel-Aviv University and an M.B.A. from Recanati Business School at Tel-Aviv University.
Erez Zino, 43, a founder the principal stockholder of the Company, became our CEO in May 2012 and became our acting CFO in January 2013. In connection with our acquisition of 66.67% of BreedIT Israel, Mr. Zino resigned as an executive officer of the Company but continues to serve as a director. During the past five years, Mr. Zino has been the owner and managing director of Ozicom Communication Ltd., a private company that provides internet marketing support. Mr. Zino is a trained computer programmer and specializes in internet marketing.
Committees of the Board of Directors
We do not presently have a separately constituted audit committee, compensation committee, nominating committee, executive committee or any other committees of our Board of directors. As such, our entire Board of directors acts as our audit committee.
Involvement in Legal Proceedings
None of our directors, nominees for directors, or officers has appeared as a party during the past ten years in any legal proceedings that may bear on his ability or integrity to serve as a director or officer of the Company.
Code of Ethics
We do not currently have a Code of Ethics applicable to our principal executive, financial and accounting officers. However, we intend to adopt such a code in or about the second quarter of 2016.
Potential Conflict of Interest
Since we do not have an audit or compensation committee comprised of independent directors, the functions that would have been performed by such committees are performed by our Board of directors. Thus, there is a potential conflict of interest in that our directors have the authority to determine issues concerning management compensation, in essence their own, and audit issues that may affect management decisions. We are not aware of any other conflicts of interest with any of our executives or directors.
Board's Role in Risk Oversight
The Board assesses on an ongoing basis the risks faced by the Company. These risks include financial, technological, competitive, and operational risks. The Board dedicates time at each of its meetings to review and consider the relevant risks faced by the Company at that time. In addition, since the Company does not have an Audit Committee, the Board is also responsible for the assessment and oversight of the Company's financial risk exposures.
Section 16(a) Compliance
Section 16(a) of the Securities and Exchange Act of 1934 requires the Registrant's directors and executive officers, and persons who own beneficially more than ten percent (10%) of the Registrant's Common Stock, to file reports of ownership and changes of ownership with the Securities and Exchange Commission. Copies of all filed reports are required to be furnished to the Registrant pursuant to Section 16(a). Based solely on the reports received by the Registrant and on written representations from reporting persons, the Registrant was informed that its officers and directors and ten percent (10%) shareholders have not filed reports required to be filed under Section 16(a).
ITEM 11. EXECUTIVE COMPENSATION Back to Table of Contents
The following table sets forth information concerning the total compensation that we have paid or that has accrued on behalf of our chief executive officer and other executive officers with annual compensation exceeding $100,000 during the fiscal years ending December 31, 2015, 2014 and 2013.
Summary Compensation Table | ||||||||
Long Term | ||||||||
Annual Compensation | Compensation Awards | |||||||
Other | Restricted | Securities | ||||||
Annual | Stock | Underlying | All Other | |||||
Salary | Bonus | Compensation | Award(s) | Options | Compensation | |||
Name and Principal Position | Year |
($) | ($) | ($) | ($) | ($) | ($) | |
Itscha Shrem, CEO and Chairman (1) | 2015 | 36,000 | --- | --- | 52,440 | --- | 52,440 | |
2014 | 36,000 | --- | --- | --- | --- | --- | ||
Oded Gilboa, CFO (2) | 2015 | 77,000 | --- | --- | --- | --- | --- | |
2014 | 48,000 | --- | --- | --- | --- | --- | ||
Erez Zino, Director, former CEO, CFO (3) | 2015 | --- | --- | --- | --- | --- | --- | |
2014 | --- | --- | --- | --- | --- | --- | ||
Yoel Yogev, former CEO and Director (4) | 2015 | 41,500 | --- | --- | --- | --- | --- | |
2014 | 46,000 | --- | --- | --- | --- | --- | ||
(1) Mr. Shrem was appointed as chairman of the board on
December 31, 2013 and was appointed as the company's CEO on November 10,
2015.
(2) Mr. Gilboa was appointed to be CFO of the Company on December
4, 2013.
(3) Mr. Zino became our CEO in July 2012 and acting CFO in
January 2013. He resigned as CFO on December 4, 2013 and as CEO on January
7, 2014 and remains a director.
(4) Mr. Yogev was appointed to the board
on January 7, 2014 and has served as the Company's CEO on from January 14,
2014 to November 10, 2015 at which time he resigned from CEO and from the
board of directors.
Option/SAR Grants
We do not currently have a stock option plan. No individual grants of stock options, whether or not in tandem with stock appreciation rights known as SARs or freestanding SARs have been made to any executive officer or any director since our inception; accordingly, no stock options have been granted or exercised by any of the officers or directors since we were founded.
Long-Term Incentive Plans and Awards
We do not have any long-term incentive plans that provide compensation intended to serve as incentive for performance. No individual grants or agreements regarding future payouts under non-stock price-based plans have been made to any executive officer or any director or any employee or consultant since our inception; accordingly, no future payouts under non-stock price-based plans or agreements have been granted or entered into or exercised by any of the officers or directors or employees or consultants since we were founded.
Compensation of Directors
There are no current arrangements pursuant to which directors are or will be compensated in the future for any services provided as a director.
Employment Contracts, Termination of Employment, Change-in-Control Arrangements
There are no employment contracts in place, no employees were terminated and no change in control arrangements have been signed with the company.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS Back to Table of Contents
The following table sets forth information regarding the beneficial ownership of our common stock as of April 4, 2016. The information in this table provides the ownership information for: each person known by us to be the beneficial owner of more than 5% of our common stock; each of our directors; each of our executive officers; and our executive officers and directors as a group.
Name of Beneficial Owner | Common Stock Beneficially Owned (1) | Percentage of Common Stock Owned (1) | ||
Itschak Shrem, CEO and Chairman | 5,600,000 | 3.88% | ||
21 Ha'Arba'h Street | ||||
Tel Aviv, Israel | ||||
Oded Gilboa, CFO | 500,000 | 0.35% | ||
23/14 Rabbi Akiva Street | ||||
Raanana, Israel | ||||
Erez Zino, Director | 9,625,000 | 6.66% | ||
40 Meri Ya'Ari Street | ||||
Tel Aviv, Israel | ||||
Doran Uziel, affiliate | 7,500,000 | 5.19% | ||
9 Hazehevit Street | ||||
Rishon Lezion, Israel | ||||
Directors and Officers (3 persons) | 15,725,000 | 10.89% |
(1) Applicable percentage ownership is based on 144,419,173 shares of common stock outstanding as of April 4, 2016. Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment power with respect to securities. Shares of common stock that are currently exercisable or exercisable within 60 days of April 4, 2016 are deemed to be beneficially owned by the person holding such securities for the purpose of computing the percentage of ownership of such person, but are not treated as outstanding for the purpose of computing the percentage ownership of any other person.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTION
S AND DIRECTORS INDEPENDENCE Back to Table of ContentsDuring the last two fiscal years the Company had the following related party transactions:
During the period from February 19, 2014 to March 4, 2014, the Company granted a total of 5,050,000 stock options (the "Options") to 4 Company directors and officers who are also minatory owners. The Options, which are fully vested, are exercisable at a price of $0.05 per Share. 1,400,000 options were valued using the Black-Scholes model with 128% volatility and 2.17% discount rate and 3,650,000 were valued using the Black-Scholes model with 154% volatility and 2.17% discount rate for a total of $2,594,210.
On January 23, 2014 to September 30, 2014 the Company sold to 1 non-US private accredited investor who is also an affiliated party 300,000 shares for total cash consideration of $30,000 at price of $0.10.
On February 18, 2014 the Company issued to Dr. Oded Sagee minority owner and founder of BreedIT Ltd., 2,200,000 shares of our common stock valued based on the closing market price on the acquisition date at $151,800; 2,200,000 Class A options for the purchase of 2,200,000 shares of our common stock at $0.055 per share valued using the black-scholes model with volatility of 122% and a discount rate of 0.23% for a total value of $84,967; and 2,200,000 Class B options for the purchase of 2,200,000 shares of our common stock at $0.065 per share valued using the black-scholes model with volatility of 122% and a discount rate of 0.23% for a total value of $84,680.
On April 14, 2014 1 share and warrant holder who is an affiliate party exercised warrants for cash consideration of $110,000, in return 2,000,000 shares were issued.
On October 2, 2014 850,000 stock options (the "Options") to 1 Company officer who is also a minority owner. The Options, vest over 9 quarters and are exercisable at a price of $0.05 per Share. The options were valued using the Black-Scholes model with 281% volatility and 0.23% discount rate for a total value of $152,955 with $52,185 expensed during Q4 2014 and $12,596 to be expenses over 8 additional quarters.
As of December 31, 2014 the Company has $18,000 in fees due and payable, $9,000 payable to one advisory board member and $9,000 payable to one Board of director members for services rendered in 2014.
On January 25, 2015 the company granted a total of 6,000,000 stock options (the "Options") to 3 Company officers who are also minority owners and 1 employee. The Options, vest over 2 quarters and are exercisable at a price of $0.10 per Share. The options were valued using the Black-Scholes model with 241% volatility and 1.33% discount rate for a total value of $429,679 with $429,629 expensed during the twelve months ended December 31, 2015.
On November 30, 2015 the Company issued 3,600,000 restricted shares of common stock in consideration for services provided to the Company to a related party. The shares were valued at $60,000 based on the closing price of the Company's common stock on the date of grant.
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES Back to Table of Contents
Independent Public Accountants
The Registrant's Board of Directors has appointed McConnell & Jones, LLP as independent public accountant for the fiscal years ended December 31, 2015 and 2014.
Principal Accounting Fees
The following table presents the fees for professional audit services rendered by M&K CPAS PLLC for the audit of the Registrant's annual financial statements for the year ended December 31, 2015 and 2014 and fees for professional audit services M&K CPAS PLLC during those periods.
Year Ended | Year Ended | ||||
December 31, 2015 | December 31, 2014 | ||||
Audit fees (1) |
$ | 10,200 | $ | 9,600 | |
Audit-related fees (2) |
--- | --- | |||
Tax fees (3) |
525 | 525 | |||
All other fees |
--- | --- | |||
(1) Audit fees consist of audit and review services, consents and review of documents filed with the SEC. | |||||
(2) Audit-related fees consist of assistance and discussion concerning financial accounting and reporting standards and other accounting issues. | |||||
(3) Tax fees consist of preparation of federal and state tax returns, review of quarterly estimated tax payments, and consultation concerning tax compliance issues. |
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
Back to Table of Contents(a) The following documents are filed as exhibits to this report on Form 10-K or incorporated by reference herein. Any document incorporated by reference is identified by a parenthetical reference to the SEC filing that included such document.
Exhibit No. | Description |
31.1 | Certification of CEO pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
31.2 | Certification of CFO pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
32.1 | Certification of CEO pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
32.2 | Certification of CFO pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned.
BREEDIT CORP.
By: /s/ Itschak Shrem
Itschak Shrem
Chief Executive Officer and Director
(Principal Executive Officer)
Date: April 4, 2016
By: /s/ Oded Gilboa
Oded Gilboa
Chief Financial Officer
(Principal Financial and Principal Accounting Officer)
Date: April 4, 2016
Pursuant to the requirements of the Securities Act of 1934, this report has been signed by
the following persons on behalf of the registrant and in the capacities and on the dates
indicated.
By: /s/
Itschak Shrem
Itschak Shrem
Chief Executive Officer and Chairman
(Principal Executive Officer)
Date: April 4, 2016
By: /s/ Oded Gilboa
Oded Gilboa
Chief Financial Officer
(Principal Financial and Principal Accounting Officer)
Date: April 4, 2015
By: /s/ Erez Zino, Director
Erez Zino
Director
Date: April 4, 2016